MUC1 and MUC16 are expressed on the surface of human airway organoid-derived air-liquid interface cultures and decreases upon StcE treatment. by Maitrayee Chatterjee (16814693)

Table_1_Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to... by Ming-Ling Chang (44638)

“…Patients with baseline cirrhosis (2.78 ± 2.56 vs. 6.84 ± 9.00 mg/dL, p=0.024) and UDCA nonresponders (2.54 ± 2.19 vs. 4.51 ± 6.99 mg/dL, p=0.006) had increased total bilirubin levels while patients without cirrhosis (AST: 91.5 ± 84.5 vs. 58.9 ± 43.7 U/L, p<0.001; ALT: 107.3 ± 122.5 vs. 50.7 ± 36.8 U/L, p<0.001) and UDCA responders (AST: 83.8 ± 101.3 vs. 45.58 ± 38.42 U/L, p=0.014; ALT: 95.10 ± 144.6 vs. 39.12 ± 30.65 U/L, p=0.009) had decreased aminotransferase levels. …”

Image_1_Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to... by Ming-Ling Chang (44638)

“…Patients with baseline cirrhosis (2.78 ± 2.56 vs. 6.84 ± 9.00 mg/dL, p=0.024) and UDCA nonresponders (2.54 ± 2.19 vs. 4.51 ± 6.99 mg/dL, p=0.006) had increased total bilirubin levels while patients without cirrhosis (AST: 91.5 ± 84.5 vs. 58.9 ± 43.7 U/L, p<0.001; ALT: 107.3 ± 122.5 vs. 50.7 ± 36.8 U/L, p<0.001) and UDCA responders (AST: 83.8 ± 101.3 vs. 45.58 ± 38.42 U/L, p=0.014; ALT: 95.10 ± 144.6 vs. 39.12 ± 30.65 U/L, p=0.009) had decreased aminotransferase levels. …”

Novel chromobox 2 inhibitory peptide decreases tumor progression by Lindsay W. Brubaker (15099942)

Cysteamine decreases TG2 and increases CFTR expression in CF. by Chandra L. Shrestha (4495837)

A set of 2 criteria for the needs of multi-criteria evaluation ‐ combinations D1–D10. by Roman Vavrek (13200141)

Glutamate exposure reduces MAP-2 immunostaining and induces changes in synaptic markers and cell adhesion molecule NCAM in the absence of neuronal death. by María Fernanda Podestá (639243)

“…<p>Hippocampal neurons in culture (DIV 12–13) were briefly exposed to 5 µM glutamate and evaluated 24 h later. (A) Microphotographs of hippocampal neurons in culture immunostained for MAP-2 or visualized by phase contrast microscopy. …”

High intergenerational growth rates correlates with decreased lifespan. by Jessica T. Smith (5488967)

Cediranib therapy decreases tumor T2, but does not affect ADC. by Christian T. Farrar (355177)

Water soaking of fruit incubated in (A) deionized water, (B) CaCl₂, (C) CuCl₂, and (D) FeCl₃. by Grecia Hurtado (10798260)

E2 induces increased chromosome conformation capture contact frequencies but decreased proximity between enhancers and promoters. by Luciana I. Gómez Acuña (18605719)

Subjects:

G0S2 stability is decreased in mice lacking ATGL. by Bradlee L. Heckmann (2818306)

Propentofylline decreases Pyk2, Rac1 and pJNK. by Valerie L. Jacobs (162560)

CK2α decreases CLK transcription factor activity. by Áron Szabó (450885)

Overexpression of Pax6 decreases Olig2 protein levels. by Eun Sook Jang (217069)

“…(<b>b</b>) Immunostaining analysis 72 hrs after transfection shows that overexpressed Pax6 decreases Olig2 levels in Oli-Neu cells. <b>(c)</b> Histogram summarizing percentage of Olig2+ cells in Oli-Neu cells after transfection<b>.…”

HAI-2 deficiency leads to decreased proliferation of intestinal epithelium. by Roman Szabo (138655)

Spinal EM2 was significantly decreased in vincristine treated rats. by Yang Yang (45629)

“…<p>(A) Compared to Sham group, EM2-like immunoreactivity in spinal dorsal horn of Vincristine group was significantly decreased. …”

Loss of Cntnap2 decreases specifically stabilization of new spines. by Amos Gdalyahu (3213810)

“…Note the absence of a significant difference between WT and Cntnap2-/- animals. <b>d.</b> The fraction of maintained spines out of the spines which were stable during the first 4 days. …”

Vasopressin decreases EPSPs in CA2 after LTP induction. by Magda Chafai (295116)

“…D) Typical graph (Left) and average graph (Right, n = 10) of EPSP amplitude <i>vs.…”

AICAR-activated AMPK decreased SREBP-2 protein levels. by Shudong Liu (733425)